Ocuphire Pharma, Inc. Profile Avatar - Palmy Investing

Ocuphire Pharma, Inc.

Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily prese…

Biotechnology
US, Farmington Hills [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of OCUP's Analysis
CIK: 1228627 CUSIP: 67577R102 LEI: - UEI: -
Secondary Listings
OCUP has no secondary listings inside our databases.